The MARS trial: mesothelioma and radical surgery

Area of Science:

• Thoracic surgery
• Oncology
• Surgical oncology

Background:

• Malignant pleural mesothelioma incidence is rising globally.
• The role of radical surgery in mesothelioma treatment is under investigation.
• There is a need to evaluate surgical outcomes for mesothelioma patients.

Purpose of the Study:

• To assess the efficacy of radical surgery in curing malignant pleural mesothelioma.
• To determine if radical surgery improves length and quality of life for mesothelioma patients.
• To establish the feasibility of the Mesothelioma and Radical Surgery (MARS) trial.

Main Methods:

• The MARS trial is currently open and recruiting patients in Britain.
• The study is designed to evaluate radical surgical approaches for mesothelioma.
• Feasibility of an international study will be assessed based on initial results.

Main Results:

• The MARS trial is actively recruiting participants.
• Preliminary feasibility data is pending.
• The study's design allows for future international expansion.

Conclusions:

• The MARS trial is investigating the potential benefits of radical surgery for malignant pleural mesothelioma.
• Further results are needed to determine the impact of this surgical approach on patient outcomes.
• Successful trial completion could lead to a larger international study.